These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2494000)
1. Nitrosation by stimulated macrophages. Inhibitors, enhancers and substrates. Kosaka H; Wishnok JS; Miwa M; Leaf CD; Tannenbaum SR Carcinogenesis; 1989 Mar; 10(3):563-6. PubMed ID: 2494000 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of nitrosamine formation by ascorbic acid. Tannenbaum SR; Wishnok JS; Leaf CD Am J Clin Nutr; 1991 Jan; 53(1 Suppl):247S-250S. PubMed ID: 1985394 [TBL] [Abstract][Full Text] [Related]
3. L-arginine-dependent formation of N-nitrosamines by the cytosol of macrophages activated with lipopolysaccharide and interferon-gamma. Ohshima H; Tsuda M; Adachi H; Ogura T; Sugimura T; Esumi H Carcinogenesis; 1991 Jul; 12(7):1217-20. PubMed ID: 1712676 [TBL] [Abstract][Full Text] [Related]
4. Catalysis and inhibition of N-nitrosation reactions. Archer MC IARC Sci Publ; 1984; (57):263-74. PubMed ID: 6398294 [TBL] [Abstract][Full Text] [Related]
5. Studies in gastric carcinogenesis. V. The effects of ascorbic acid on N-nitroso compound formation in human gastric juice in vivo and in vitro. Kyrtopoulos SA; Pignatelli B; Karkanias G; Golematis B; Esteve J Carcinogenesis; 1991 Aug; 12(8):1371-6. PubMed ID: 1860156 [TBL] [Abstract][Full Text] [Related]
6. In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia. Moriya A; Grant J; Mowat C; Williams C; Carswell A; Preston T; Anderson S; Iijima K; McColl KE Scand J Gastroenterol; 2002 Mar; 37(3):253-61. PubMed ID: 11916186 [TBL] [Abstract][Full Text] [Related]
7. Nitrosation of amines by stimulated macrophages. Miwa M; Stuehr DJ; Marletta MA; Wishnok JS; Tannenbaum SR Carcinogenesis; 1987 Jul; 8(7):955-8. PubMed ID: 2439225 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of bacterially mediated N-nitrosation by ascorbate: therapeutic and mechanistic considerations. Leach SA; Mackerness CW; Hill MJ; Thompson MH IARC Sci Publ; 1991; (105):571-8. PubMed ID: 1855920 [TBL] [Abstract][Full Text] [Related]
9. N-nitroso compound formation in human gastric juice. Kyrtopoulos SA Cancer Surv; 1989; 8(2):423-42. PubMed ID: 2696588 [TBL] [Abstract][Full Text] [Related]
10. Accelerating effect of ascorbic acid on N-nitrosamine formation and nitrosation by oxyhyponitrite. Chang SK; Harrington GW; Rothstein M; Shergalis WA; Swern D; Vohra SK Cancer Res; 1979 Oct; 39(10):3871-4. PubMed ID: 38902 [TBL] [Abstract][Full Text] [Related]
11. Theoretical model for predicting rates of nitrosamine and nitrosamide formation in the human stomach. Licht WR; Deen WM Carcinogenesis; 1988 Dec; 9(12):2227-37. PubMed ID: 3191569 [TBL] [Abstract][Full Text] [Related]
12. N-nitrosation of medicinal drugs catalysed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori. Ziebarth D; Spiegelhalder B; Bartsch H Carcinogenesis; 1997 Feb; 18(2):383-9. PubMed ID: 9054633 [TBL] [Abstract][Full Text] [Related]
13. Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia. Suzuki H; Iijima K; Moriya A; McElroy K; Scobie G; Fyfe V; McColl KE Gut; 2003 Aug; 52(8):1095-101. PubMed ID: 12865265 [TBL] [Abstract][Full Text] [Related]
14. Influence of ascorbic acid on the endogenous (intragastral) formation of N-nitroso compounds. Schmähl D; Eisenbrand G Int J Vitam Nutr Res Suppl; 1982; 23():91-102. PubMed ID: 6811491 [TBL] [Abstract][Full Text] [Related]
15. The inhibition of bacterially mediated N-nitrosation by vitamin C: relevance to the inhibition of endogenous N-nitrosation in the achlorhydric stomach. Mackerness CW; Leach SA; Thompson MH; Hill MJ Carcinogenesis; 1989 Feb; 10(2):397-9. PubMed ID: 2492212 [TBL] [Abstract][Full Text] [Related]
16. Bacterial catalysis of nitrosation: involvement of the nar operon of Escherichia coli. Ralt D; Wishnok JS; Fitts R; Tannenbaum SR J Bacteriol; 1988 Jan; 170(1):359-64. PubMed ID: 3275620 [TBL] [Abstract][Full Text] [Related]
17. Effect of ascorbic acid on the intragastric environment in patients at increased risk of developing gastric cancer. Reed PI; Johnston BJ; Walters CL; Hill MJ IARC Sci Publ; 1991; (105):139-42. PubMed ID: 1855837 [TBL] [Abstract][Full Text] [Related]
18. Use of ascorbic acid to inhibit nitrosation: kinetic and mass transfer considerations for an in vitro system. Licht WR; Tannenbaum SR; Deen WM Carcinogenesis; 1988 Mar; 9(3):365-72. PubMed ID: 3345578 [TBL] [Abstract][Full Text] [Related]
19. Nitrosating agents: is peroxynitrite a likely candidate? Williams DL Nitric Oxide; 1997; 1(6):522-7. PubMed ID: 9466958 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitrosamine formation by ascorbic acid. Tannenbaum SR; Wishnok JS Ann N Y Acad Sci; 1987; 498():354-63. PubMed ID: 3304066 [No Abstract] [Full Text] [Related] [Next] [New Search]